Recap: G1 Therapeutics Q3 Earnings


G1 Therapeutics GTHX reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM.

Here's what investors need to know about the announcement.


G1 Therapeutics reported in-line EPS of $-1.0 versus an estimate of $-1.0, which did not surprise analysts.

Revenue was up $21,741,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03, which was followed by a 3.35% drop in the share price the next day.

Here's a look at G1 Therapeutics's past performance:


Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.97 -1.07 -0.87 -0.30
EPS Actual -0.94 -0.65 -0.67 -0.31
Revenue Estimate 2.59M 770.00K 4.06M 28.57M
Revenue Actual 6.60M 14.22M 16.55M 26.60M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!